Two Sigma Investments
CPIX icon

Two Sigma Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Two Sigma Investments’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
23,981
+12,896
+116% +$61.8K ﹤0.01% 4834
2026
Q1 		$36K Sell
11,085
-13,400
-55% -$51.6K ﹤0.01% 4483
2025
Q4 		$97.5K Sell
24,485
-13,106
-35% -$38.8K ﹤0.01% 3859
2025
Q3 		$117K Buy
37,591
+5,326
+17% +$17.7K ﹤0.01% 3452
2025
Q2 		$108K Buy
32,265
+9,510
+42% +$45K ﹤0.01% 2988
2025
Q1 		$96.3K Sell
22,755
-14,894
-40% -$61.8K ﹤0.01% 2970
2024
Q4 		$89.2K Buy
37,649
+18,271
+94% +$26.9K ﹤0.01% 2983
2024
Q3 		$24.8K Buy
19,378
+48
+0.2% +$66 ﹤0.01% 3012
2024
Q2 		$29.6K Sell
19,330
-13,100
-40% -$20.6K ﹤0.01% 2918
2024
Q1 		$54.5K Sell
32,430
-600
-2% -$1.2K ﹤0.01% 2880
2023
Q4 		$59.2K Sell
33,030
-200
-0.6% -$367 ﹤0.01% 2982
2023
Q3 		$62.8K Hold
33,230
– – ﹤0.01% 2793
2023
Q2 		$48.8K Sell
33,230
-200
-0.6% -$345 ﹤0.01% 2835
2023
Q1 		$65.2K Sell
33,430
-5,000
-13% -$11.9K ﹤0.01% 2720
2022
Q4 		$86.5K Sell
38,430
-6,785
-15% -$15.7K ﹤0.01% 2526
2022
Q3 		$109K Sell
45,215
-6,287
-12% -$14.8K ﹤0.01% 2218
2022
Q2 		$107K Sell
51,502
-37,581
-42% -$86.9K ﹤0.01% 2261
2022
Q1 		$251K Buy
89,083
+6,163
+7% +$20.5K ﹤0.01% 2272
2021
Q4 		$387K Buy
+82,920
New +$283K ﹤0.01% 3462
2014
Q1 		– Sell
-38,485
Closed -$197K – 2024
2013
Q4 		$197K Buy
38,485
+14,585
+61% +$71.2K ﹤0.01% 2015
2013
Q3 		$108K Sell
23,900
-1,300
-5% -$6.47K ﹤0.01% 1735
2013
Q2 		$129K Buy
+25,200
New +$125K ﹤0.01% 1864

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Two Sigma Investments's CPIX Position: Q2 2026 in Review

Two Sigma Investments increased its Cumberland Pharmaceuticals (CPIX) stake by 116% in Q2 2026, buying an estimated $61.8K and bringing the position to 23,981 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #4834.

Two Sigma Investments first reported a position in CPIX in Q2 2013 and has held it in 22 quarters since. The position peaked at $387K in Q4 2021. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Two Sigma Investments held 23,981 shares of Cumberland Pharmaceuticals worth $155K as of Q2 2026.
  • Two Sigma Investments bought 12,896 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $61.8K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4834 holding.
  • Two Sigma Investments first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
  • Two Sigma Investments's Cumberland Pharmaceuticals position peaked at $387K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.